6.
Fullerton H, Stratton K, Mueller S, Leisenring W, Armstrong G, Weathers R
. Recurrent stroke in childhood cancer survivors. Neurology. 2015; 85(12):1056-64.
PMC: 4603599.
DOI: 10.1212/WNL.0000000000001951.
View
7.
Rebholz C, Reulen R, Toogood A, Frobisher C, Lancashire E, Winter D
. Health care use of long-term survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol. 2011; 29(31):4181-8.
DOI: 10.1200/JCO.2011.36.5619.
View
8.
Colao A, Marzullo P, Di Somma C, Lombardi G
. Growth hormone and the heart. Clin Endocrinol (Oxf). 2001; 54(2):137-54.
DOI: 10.1046/j.1365-2265.2001.01218.x.
View
9.
Zhang S, Li Z, Lv Y, Sun L, Xiao X, Gang X
. Cardiovascular effects of growth hormone (GH) treatment on GH-deficient adults: a meta-analysis update. Pituitary. 2020; 23(4):467-475.
DOI: 10.1007/s11102-020-01036-0.
View
10.
Braverman A, Antin J, Plappert M, Cook E, Lee R
. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol. 1991; 9(7):1215-23.
DOI: 10.1200/JCO.1991.9.7.1215.
View
11.
Warris L, van den Akker E, Bierings M, van den Bos C, Zwaan C, Sassen S
. Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone. PLoS One. 2016; 11(6):e0158225.
PMC: 4928792.
DOI: 10.1371/journal.pone.0158225.
View
12.
Kamphuis J, Linschoten M, Cramer M, Gort E, van Rhenen A, Asselbergs F
. Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics: What Is the Evidence?. JACC CardioOncol. 2021; 1(2):280-290.
PMC: 8352330.
DOI: 10.1016/j.jaccao.2019.09.007.
View
13.
Goldberg M, Antin J, Guinan E, Rappeport J
. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood. 1986; 68(5):1114-8.
View
14.
Agha A, Sherlock M, Brennan S, OConnor S, OSullivan E, Rogers B
. Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab. 2005; 90(12):6355-60.
DOI: 10.1210/jc.2005-1525.
View
15.
Duerr R, Huang S, Miraliakbar H, Clark R, Chien K, ROSS Jr J
. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 1995; 95(2):619-27.
PMC: 295527.
DOI: 10.1172/JCI117706.
View
16.
Fernandez A, Brada M, Zabuliene L, Karavitaki N, Wass J
. Radiation-induced hypopituitarism. Endocr Relat Cancer. 2009; 16(3):733-72.
DOI: 10.1677/ERC-08-0231.
View
17.
van Dijk I, van der Pal H, van Os R, Roos Y, Sieswerda E, van Dalen E
. Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis. Int J Radiat Oncol Biol Phys. 2016; 96(3):597-605.
DOI: 10.1016/j.ijrobp.2016.03.049.
View
18.
Frankart A, Nagarajan R, Pater L
. The impact of proton therapy on cardiotoxicity following radiation treatment. J Thromb Thrombolysis. 2020; 51(4):877-883.
DOI: 10.1007/s11239-020-02303-4.
View
19.
Hanchate L, Sharma S, Madyalkar S
. Cisplatin Induced Acute Myocardial Infarction and Dyslipidemia. J Clin Diagn Res. 2017; 11(6):OD05-OD07.
PMC: 5535418.
DOI: 10.7860/JCDR/2017/25546.10025.
View
20.
Kupari M, Volin L, Suokas A, Timonen T, Hekali P, Ruutu T
. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant. 1990; 5(2):91-8.
View